Quarterly report pursuant to Section 13 or 15(d)

Stock-based Payments (Tables)

v3.24.1.1.u2
Stock-based Payments (Tables)
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options Activity

The following table summarizes the activities for MyMD stock options for the three months ended March 31, 2024:

                      Weighted        
                      Average        
          Weighted     Weighted     Remaining        
          Average     Average     Contractual     Aggregate  
    Number of     Exercise     Grant Date     Term     Intrinsic  
    Shares     Price     Fair Value     (years)     Value  
Balance at December 31, 2023     139,840     $ 46.09     $ 42.34       8.17     $ -  
Granted     -       -       -       -       -  
Exercised     -       -       -       -       -  
Forfeited     -       -       -       -       -  
Canceled/Expired     -       -       -       -       -  
Balance at March 31, 2024     139,840     $ 46.09     $ 42.34       7.92     $ -  
Exercisable as of March 31, 2024     47,286     $ 56.44     $ 51.49       7.23     $ -  
Summary of Restricted Stock Units Activity

The following is the status of outstanding unvested restricted stock units outstanding as of March 31, 2024 and the changes for the three months ended March 31, 2024:

Summary of Restricted Stock Units Activity

          Weighted  
          Average  
    Number of     Grant Date  
    RSUs     Fair Value  
Balance at December 31, 2023     88,668     $ 242.70  
Granted     -       -  
Vested     -       -  
Forfeited     -       -  
Canceled/Expired     -       -  
Balance at March 31, 2024     88,668     $ 242.70